The emergence of Cognitive Computing for Cancer has revolutionized the healthcare industry. This technique is allowing a previously unattainable level of personalized treatment options with efficiency and simplicity. Due to this ability, it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences.
The report provides an insight of the current and future prospective of this market. This report covers the major opportunities in this area, and the factors impacting the market growth. Furthermore, the report also provides insight regarding the trends persisting in the market.
The report contains the Cancer Cognitive Computing market share of major regions, including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest market share, while Asia-Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth in Asia-Pacific are the ongoing researches in China and Japan, which is expanding cognitive computing applications to oncology. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in this market.
Alacris Theranostics GmbH
Enterra Solutions, LLC
Lockheed Martin Corporation
Saffron Technology, Inc.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Cognitive Computing for Cancer: An Overview
4. Market Dynamics
5. Cancer Demographics
6. Cancer Cognitive Computing Market Outlook
7. Trends & Developments in Cancer Cognitive Computing